Research
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7498 (Published 13 November 2012) Cite this as: BMJ 2012;345:e7498Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Supplementary data file, including database search strategy and supplementary figures [posted as supplied by author]
Related articles
- Clinical Review Published: 20 February 2013; BMJ 346 doi:10.1136/bmj.f757
- Research Published: 30 August 2013; BMJ 347 doi:10.1136/bmj.f5133
- Editorial Published: 09 September 2013; BMJ 347 doi:10.1136/bmj.f5440
- Research Methods & Reporting Published: 27 April 2015; BMJ 350 doi:10.1136/bmj.h1845
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week
- Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study
- How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy
- Setting number of decimal places for reporting risk ratios: rule of four
- Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism
- The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
- Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- The newer direct oral anticoagulants: a practical guide
- Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
- Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD
- Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
- Almanac 2013: Novel non-coronary cardiac interventions
- Secondary prevention of venous thromboembolism
- Diagnosis and management of pulmonary embolism
- Novel Oral Anticoagulants Are as Effective as Vitamin K Antagonists for Patients with Acute VTE